Medacta Ebit from 2010 to 2026
| MOVE Stock | 151.60 1.40 0.93% |
EBIT | First Reported 2015-12-31 | Previous Quarter 49.7 M | Current Value 60.6 M | Quarterly Volatility 13.9 M |
Check Medacta Group financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Medacta Group's main balance sheet or income statement drivers, such as Tax Provision of 9.6 M, Interest Income of 241.4 K or Depreciation And Amortization of 78.8 M, as well as many indicators such as Price To Sales Ratio of 6.38, Dividend Yield of 0.0054 or PTB Ratio of 12.45. Medacta financial statements analysis is a perfect complement when working with Medacta Group Valuation or Volatility modules.
Medacta | Ebit |
The evolution of Ebit for Medacta Group SA provides essential context for understanding the company's financial health trajectory. By analyzing this metric's behavior over time, investors can assess whether recent trends align with long-term patterns, and how Medacta Group compares to historical norms and industry peers.
Latest Medacta Group's Ebit Growth Pattern
Below is the plot of the Ebit of Medacta Group SA over the last few years. It is Medacta Group's EBIT historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Medacta Group's overall financial position and show how it may be relating to other accounts over time.
| Ebit | 10 Years Trend |
|
Ebit |
| Timeline |
Medacta Ebit Regression Statistics
| Arithmetic Mean | 61,009,699 | |
| Geometric Mean | 58,830,750 | |
| Coefficient Of Variation | 30.29 | |
| Mean Deviation | 14,155,375 | |
| Median | 49,810,000 | |
| Standard Deviation | 18,478,760 | |
| Sample Variance | 341.5T | |
| Range | 69.5M | |
| R-Value | 0.74 | |
| Mean Square Error | 166T | |
| R-Squared | 0.54 | |
| Significance | 0.0007 | |
| Slope | 2,699,814 | |
| Total Sum of Squares | 5463.4T |
Medacta Ebit History
About Medacta Group Financial Statements
Medacta Group investors use historical fundamental indicators, such as Medacta Group's Ebit, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in Medacta Group. Please read more on our technical analysis and fundamental analysis pages.
| Last Reported | Projected for Next Year | ||
| EBIT | 109.6 M | 68.5 M | |
| EBITDA | 184.6 M | 105.8 M | |
| Ebt Per Ebit | 1.11 | 0.94 | |
| Ebit Per Revenue | 0.18 | 0.19 |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Additional Tools for Medacta Stock Analysis
When running Medacta Group's price analysis, check to measure Medacta Group's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Medacta Group is operating at the current time. Most of Medacta Group's value examination focuses on studying past and present price action to predict the probability of Medacta Group's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Medacta Group's price. Additionally, you may evaluate how the addition of Medacta Group to your portfolios can decrease your overall portfolio volatility.